Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
SUMMARY: This study shows that subcutaneous administration of increasing doses of IL-12, once a week, in 21 cancer patients increased the expression of cytokine genes (interferon-gamma (IFN-γ), tumour necrosis factor-alpha (TNF-α), IP-10, MIG, IL-10, IL-4) in peripheral blood mononuclear cells even at very low doses (30 ng/kg). Surprisingly, no circulating TNF-α or IL-4 could be detected in the plasma of patients treated with IL-12. However, a marked increase of soluble IL-4 receptor was demonstrated in the plasma of five of the six patients studied, which may represent an additional mechanism by which IL-12 inhibits the development of the Th2 response in vivo. A marked decline of IFN-γ and IP10 induction was recorded after repeated cycles of IL-12. In contrast, in most patients IL-12 increased IL-10 expression with no subsequent decrease during the course of therapy, and even an earlier peak of IL-10 induction at the 6th cycle. In addition, a constant up-regulation of serum soluble IFN-γ receptor levels was observed after each cycle of IL-12 treatment with a delayed peak compared with the IFN-γ peak. The constant rise of IL-10 and soluble IFN-γ receptor during IL-12 therapy may therefore contribute to the inhibition of IFN-γ activity detected after repeated cycles of IL-12. Lastly, a marked heterogeneity of cytokine induction was observed from one patient to another, which appeared to be independent of the dose of IL-12 administered. These data may lead to a better understanding of the biological activity of IL-12 and the in vivo mechanisms of its regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
Self-citationInterleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Clinical Trials: IL-12 Deaths: Explanation and a Puzzle
Cohen, J. (1995) · Science · doi:10.1126/science.270.5238.908a · Cited by 332
Cited by
Interleukin 12: still a promising candidate for tumor immunotherapy?
Lasek, W., Zagożdżon, R., & Jakobisiak, M. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1523-1 · Cited by 495
“These effects were associated with IFN-γ production, and further on, two more downstream mediators were described: IFN-γ-inducible protein 10 (IP-10, CXCL10) and monokine induced by IFN-γ (MIG, CXCL9) [41].”
BackgroundMethodInfluentialInterleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism
Benchetrit, F., Ciree, A., Vives, V., Warnier, G., Gey, A., Sautès-Fridman, C., Fossiez, F., Haicheur, N., Fridman, W. H., & Tartour, E. (2002) · Blood · doi:10.1182/blood.v99.6.2114 · Cited by 347
Self-citationChemical modification of chitosan as a gene carrier in vitro and in vivo
Kim, T.-H., Jiang, H.-L., Jere, D., Park, I.-K., Cho, M.-H., Nah, J.-W., Choi, Y.-J., Akaike, T., & Cho, C.-S. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.001 · Cited by 322
Tartour, E., Pere, H., Maillere, B., Terme, M., Merillon, N., Taieb, J., Sandoval, F., Quintin-Colonna, F., Lacerda, K., Karadimou, A., et al. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9281-4 · Cited by 316
Self-citationIL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production
Mitola, S., Strasly, M., Prato, M., Ghia, P., & Bussolino, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3725 · Cited by 58
Metadata
- Authors
- Haicheur, N., Escudier, B., Dorval, T., Negrier, S., De Mulder, P. H. M., Dupuy, J. M., Novick, D., Guillot, T., Wolf, S., Pouillart, P., Fridman, W. H., & Tartour, E.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01
- Volume
- 119
- Issue
- 1
- Pages
- 28-37
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2075526337
- Cited by
- 78
- References
- 3
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. https://app.cochat.ai/papers/10.1046/j.1365-2249.2000.01112.x
- The paper
- Haicheur, N., Escudier, B., Dorval, T., Negrier, S., De Mulder, P. H. M., Dupuy, J. M., Novick, D., Guillot, T., Wolf, S., Pouillart, P., Fridman, W. H., & Tartour, E. (2002). Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clinical and Experimental Immunology. https://doi.org/10.1046/j.1365-2249.2000.01112.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.